Merck inks a licensing deal worth nearly $2B with China’s Jiangsu Hengrui
Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...
MarketWatch4d
Merck, Hengrui Pharma in Lipoprotein(a) Licensing Deal
Merck & Co. has agreed to license an investigational ... stroke and other cardiovascular diseases. The Rahway, N.J., drugmaker said Hengrui Pharma will be eligible to receive up to an additional ...
Merck to close Pennsylvania plant
Pharmaceutical giant Merck will close its plant in Northumberland County, Pennsylvania. According to a WARN Notice filed with ...
NJBIZ18d
Merck opens $1B vaccine production facility (updated)
Merck opened a 225,000-square-foot facility dedicated solely to expanding vaccine manufacturing. The Rahway-based research-intensive biopharmaceutical announced the launch of the $1 billion ...
Business Wire18d
Merck Unveils New Facility to Increase Vaccine Production Capacity
DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...